Abbott Laboratories (ABT)

Payables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 31,388,000 31,708,000 31,742,000 32,218,000 32,920,000 32,724,000 32,056,000 31,532,000 30,940,000 30,164,000 29,242,000 27,108,000 25,804,000 24,527,000 24,057,000 24,231,000 23,965,000 23,673,000 23,418,000 23,453,000
Payables US$ in thousands 4,295,000 3,961,000 4,211,000 4,167,000 4,607,000 4,133,000 4,493,000 4,757,000 4,408,000 4,017,000 4,017,000 4,066,000 3,946,000 3,189,000 3,335,000 3,181,000 3,252,000 3,029,000 3,222,000 3,045,000
Payables turnover 7.31 8.01 7.54 7.73 7.15 7.92 7.13 6.63 7.02 7.51 7.28 6.67 6.54 7.69 7.21 7.62 7.37 7.82 7.27 7.70

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $31,388,000K ÷ $4,295,000K
= 7.31

The payables turnover ratio for Abbott Laboratories has shown some fluctuation over the past eight quarters, ranging from a low of 4.02 in Q2 2022 to a high of 4.67 in Q3 2022. The average payables turnover ratio for this period is approximately 4.34.

A high payables turnover ratio indicates that the company is efficiently managing its accounts payable by paying its suppliers quickly. This can be positive as it suggests strong supplier relationships and the ability to take advantage of early payment discounts.

On the other hand, a low payables turnover ratio could indicate that the company is taking longer to pay its suppliers, potentially straining supplier relationships or missing out on early payment discounts. It could also suggest inefficiencies in the company's payables management processes.

Overall, Abbott Laboratories' payables turnover ratio has been relatively stable around the industry average, indicating that the company is effectively managing its accounts payable. However, it is important for Abbott Laboratories to continue monitoring and improving its payables turnover ratio to ensure optimal working capital management and strong supplier relationships.


Peer comparison

Dec 31, 2023


See also:

Abbott Laboratories Payables Turnover (Quarterly Data)